Skip to main content
CBUS
NASDAQ Industrial Applications And Services

Cibus Finalizes $20M Equity Offering Critical for Operations; Directors Invest $1.5M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.75
Mkt Cap
$104.224M
52W Low
$1.09
52W High
$3.4
52W Position info
61% above low
Off High info
49% below high
Rel. Volume info
3.4× avg
Market data snapshot near publication time

CBUS sits 61% above its 52-week low of $1.09 on elevated volume (3.4× avg).

Summary

Cibus, Inc. finalized a $20 million equity offering at a discount to market, crucial for its going concern status, with significant participation from Board members investing $1.5 million.


Key Events · Financing and Capital Events · CBUS

  • Finalizes Equity Offering Terms

    Cibus, Inc. finalized the terms and pricing of an equity offering initiated on January 28, 2026, selling 13,333,333 shares of Class A Common Stock at $1.50 per share.

  • Secures Substantial Capital

    The offering is expected to generate approximately $17.8 million in net proceeds, or up to $20.5 million if the underwriter's option to purchase additional shares is fully exercised. These funds are intended for working capital and general corporate purposes, including funding core Rice weed management traits.

  • Highly Dilutive Event

    The offering represents a highly dilutive event, increasing the number of outstanding shares by over 25% and resulting in an immediate dilution of $4.46 per share for new investors.

  • Critical for Going Concern

    The company explicitly stated that its ability to continue as a going concern depends on obtaining additional financing, making this capital raise a critical step for its operational viability.


Analysis · CBUS · Industrial Applications And Services

Cibus, Inc. has finalized the terms of its previously announced equity offering, raising approximately $17.8 million in net proceeds (or $20.5 million if the underwriter's option is fully exercised). This offering is critical for the company's ability to continue as a going concern, as explicitly stated in the filing. The offering involves the sale of 13,333,333 shares of Class A Common Stock at $1.50 per share, representing a substantial capital raise and highly dilutive event for existing shareholders, with an immediate dilution of $4.46 per share for new investors. Notably, members of the Board of Directors are participating by purchasing 999,999 shares, totaling approximately $1.5 million, demonstrating significant insider confidence amidst the company's financial challenges and strategic pivot to preserve capital.

At the time of this filing, CBUS was trading at $1.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $104.2M. The 52-week trading range was $1.09 to $3.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBUS - Latest Insights

CBUS
Jun 17, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $1.94 info
Change: +$0.620 (+47%) info
Market Cap: $148.083M info
CBUS
Jun 09, 2026, 8:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.23
Real-time Price: $1.94 info
Change: +$0.710 (+58%) info
Market Cap: $148.083M info
CBUS
May 22, 2026, 4:59 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.94 info
Change: +$0.590 (+44%) info
Market Cap: $148.083M info
CBUS
May 15, 2026, 4:47 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $1.94 info
Change: +$0.6196 (+47%) info
Market Cap: $148.083M info
CBUS
May 15, 2026, 4:28 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $1.32
Real-time Price: $1.94 info
Change: +$0.6196 (+47%) info
Market Cap: $148.083M info